Global Point of Care (PoC) Lipid Test Market, By Product (Consumables and Instruments), Application (Hyperlipidemia, Hypertriglyceridemia, Hyperlipoproteinemia, Tangier Disease, Familial Hypercholesterolemia and Others), Disease Indication (Lipid and Lipoprotein Disorders, Atherosclerosis, Liver and Renal Diseases, Diabetes Mellitus, Others), Mode (OTC-Based Testing and Prescription-Based Testing), End-User (Hospitals, Clinics, Research and Diagnostic Laboratories and Others) – Industry Trends and Forecast to 2030.
Point of Care (PoC) Lipid Test Market Analysis and Size
Increased investment in healthcare facilities and technologies has resulted in an increase in demand for point-of-care (POC) lipid test devices. Another factor driving the growth of the point of care (POC) lipid test market is the increasing number of patients suffering from diabetes, cardiovascular disease, obesity, and other diseases. A surge in technology awareness has also resulted in an increase in demand for this technology.
Data Bridge Market Research analyses that the point of care (PoC) lipid test market which is USD 2.86 million in 2022, is expected to reach USD 4.17 million by 2030, at a CAGR of 4.84% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Point of Care (PoC) Lipid Test Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Consumables and Instruments), Application (Hyperlipidemia, Hypertriglyceridemia, Hyperlipoproteinemia, Tangier Disease, Familial Hypercholesterolemia and Others), Disease Indication (Lipid and Lipoprotein Disorders, Atherosclerosis, Liver and Renal Diseases, Diabetes Mellitus, Others), Mode (OTC-Based Testing and Prescription-Based Testing), End-User (Hospitals, Clinics, Research and Diagnostic Laboratories and Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Abbott (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), BD (U.S.), Siemens Healthcare Private Limited (Germany), Bio-Rad Laboratories, Inc. (U.S.), Danaher (U.S), Sekisui Diagnostics (U.S.), Trinity Biotech (Ireland), BIOMÉRIEUX (France), EKF Diagnostics (Germany), AccuBioTech Co., Ltd. (China), Instrumentation Laboratory (U.S.), Beckman Coulter, Inc. (U.S.), PTS Diagnostics (U.S.), Nova Biomedical (U.S.), Chembio Diagnostics, Inc. (U.S.), Quidel Corporation (U.S) and Sienco, Inc (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Points of care (POC) tests are medical tests that aid in the diagnosis of a problem in the human body at a specific point. The point of care tests aid in providing real-time results in a matter of minutes. As a result, a point of care (POC) lipid test is performed to assess the function of the lipid in the cells. When cholesterol levels rise, it disrupts the functioning of lipids in the body, leading to serious illnesses such as heart attack and coronary artery disease.
Point of Care (PoC) Lipid Test Market Dynamics
Drivers
- Point of care (PoC) lipid test to gain traction for liver and renal diseases
Rising cases of chronic diseases such as liver and renal diseases, as well as diabetes, are expected to drive the global point of care (PoC) lipid test market during the forecast period. Cardiovascular disease is the leading cause of death in chronic kidney disease patients (CVD). One of the most important pathophysiological mechanisms for CVD in CKD patients is the widespread and possibly increased formation of atherosclerotic plaques due to hyperlipidemia, uremic toxins, inflammation, and endothelial dysfunction. According to the US Department of Health and Human Services, chronic kidney disease (CKD) affects more than one in every seven adults in the US, or approximately 37 million people. These are the certain factors which propel the market growth.
Opportunities
- Rising demand for technological advancements
Rising demand for technological advancements that improve speed, accuracy, and user-friendliness, as well as increasing market penetration rates of technologies such as self-testing handheld devices, are expected to drive demand. For instance, Polymer Technology Systems Inc., introduced the CardioChek Plus analyzer, an advanced version of its point-of-care multi-analyte system, in 2013. Sedentary lifestyles and unhealthy lifestyle habits are expected to provide manufacturers with an ever-expanding user base.
Restraints/Challenges
- High cost
The rising cost of point-of-care (POC) lipid tests will limit the market's growth. It comes with the additional cost of $2500.00. Furthermore, the scarcity of lab services in rural areas, particularly in developing countries, will hamper the market growth. The lack of trained professionals in these fields will also limit market growth opportunities.
This point of care (PoC) lipid test market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the point of care (PoC) lipid test market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Point of Care (PoC) Lipid Test Market Scope
The point of care (PoC) lipid test market is segmented on the basis of product, application, disease indication, mode and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Consumables
- Test Strips
- Cassette
- Others
- Instruments
Disease Indication
- Lipid and Lipoprotein Disorders
- Hyperlipidemia
- Hypertriglyceridemia
- Familial Hypercholesterolemia
- Hyperlipoproteinemia
- Others
- Atherosclerosis
- Liver and Renal Diseases
- Diabetes Mellitus
- Others
Application
- Hyperlipidemia
- Hypertriglyceridemia
- Hyperlipoproteinemia
- Tangier Disease
- Familial Hypercholesterolemia
- Others
Mode
- OTC-Based Testing
- Prescription-Based Testing
End-User
- Hospitals
- Clinics
- Research and Diagnostic Laboratories
- Others
Point of Care (PoC) Lipid Test Market Regional Analysis/Insights
The point of care (PoC) lipid test market is analysed and market size insights and trends are provided by country, product, application, disease indication, mode and end-user as referenced above.
The countries covered in the point of care (PoC) lipid test market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the point of care (PoC) lipid test market owing to the prevalence of high number of patients with cardiovascular diseases.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 owing to rising levels of obesity in the individuals and developing healthcare facilities.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The point of care (PoC) lipid test market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for point of care (PoC) lipid test market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the point of care (PoC) lipid test market. The data is available for historic period 2011-2021.
Competitive Landscape and Point of Care (PoC) Lipid Test Market Share Analysis
The point of care (PoC) lipid test market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to point of care (PoC) lipid test market.
Some of the major players operating in the point of care (PoC) lipid test market are:
- Abbott (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- BD (U.S.)
- Siemens Healthcare Private Limited (Germany)
- Bio-Rad Laboratories, Inc. (U.S.)
- Danaher (U.S.)
- Sekisui Diagnostics (U.S.)
- Trinity Biotech (Ireland)
- BIOMÉRIEUX (France)
- EKF Diagnostics (Germany)
- AccuBioTech Co., Ltd. (China)
- Instrumentation Laboratory (U.S.)
- Beckman Coulter, Inc. (U.S.)
- PTS Diagnostics (U.S.)
- Nova Biomedical (U.S.)
- Chembio Diagnostics, Inc. (U.S.)
- Quidel Corporation (U.S.)
- Sienco, Inc (U.S.)
SKU-